UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended October 1, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 001-41697 Kenvue Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 1 ...

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 001-41697 Kenvue Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 2, 2023 or (Exact name of registrant as specified in its charter) Delaware 88-1032011 (State or other jurisdiction of incorporation o ...

Financial Performance - Reported net sales increased by 5.4% to $4 billion, with organic growth of 7.7%[21] - Full year 2023 organic growth is expected to be between 5.5% and 6.5%[21] - Reported EPS was $0.23, and adjusted EPS was $0.32[21] - Adjusted gross profit margin was 59.3% in Q2 2023 compared to 57.5% in Q2 2022[49] - Adjusted EBITDA margin was 24.5% in Q2 2023 compared to 26.8% in Q2 2022[51] - Adjusted net income was $581 million in Q2 2023 compared to $732 million in Q2 2022[54] Segment Performance - Self Care segment reported net sales increased 12.2%, with organic growth of 14.2%[44] - Skin Health & Beauty segment reported net sales increased 1.9%, with organic growth of 3.4%[44] - Essential Health segment reported net sales increased 0.5%, with organic growth of 3.8%[46] Guidance - The company anticipates a reported net sales growth between 4.5% and 5.5% for fiscal year 2023[59] - The company anticipates adjusted earnings per share between $1.26 and $1.31 for fiscal year 2023[59]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 2, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 001-41697 Kenvue Inc. (Exact name of registrant as specified in its charter) Delaware 88-1032011 (State or other jurisdiction of incorporation ...